OBJECTIVE: To assess the psychometric performance of using standard gamble (SG), time trade-off (TTO) and visual analogue scale (VAS) in the evaluation of three predetermined HIV/AIDS health states in HIV-infected Ugandans, for use in cost-effectiveness analyses. METHODS: We recruited participants with CD4 cells <200/microl from the Development of AntiRetroviral Therapy in Africa (DART) trial cohort [randomized trial evaluating antiretroviral therapy (ART) management strategies] in Uganda, before they initiated ART (n = 276). A comparison group of ART-naive HIV-infected individuals was recruited from the Entebbe Cohort study (n = 159). Participants were interviewed and asked to rate his/her own health state using VAS; rank and evaluate HIV/AIDS predetermined health states using TTO and SG relative to an improved health state. Tools were tested for psychometrical properties. RESULTS: Women constituted 64% and 76% of the DART and Entebbe Cohorts. Mean age was 36.5 and 36.7 years, respectively. Participants could discriminate between predetermined HIV/AIDS health states. Deterioration in health status was associated with a reduction in rating scores (VAS), increased willingness to give up time (TTO) and acceptance of increased risk (SG) to achieve a better health state, independent of the participant's actual health state, as measured by CD4 cell counts. CONCLUSION: VAS, TTO and SG have good psychometric properties, making them good candidates for use in resource-constrained settings. Further research in a wider population is necessary to generate an evidence base with which to inform resource allocation decisions.
OBJECTIVE: To assess the psychometric performance of using standard gamble (SG), time trade-off (TTO) and visual analogue scale (VAS) in the evaluation of three predetermined HIV/AIDS health states in HIV-infected Ugandans, for use in cost-effectiveness analyses. METHODS: We recruited participants with CD4 cells <200/microl from the Development of AntiRetroviral Therapy in Africa (DART) trial cohort [randomized trial evaluating antiretroviral therapy (ART) management strategies] in Uganda, before they initiated ART (n = 276). A comparison group of ART-naive HIV-infected individuals was recruited from the Entebbe Cohort study (n = 159). Participants were interviewed and asked to rate his/her own health state using VAS; rank and evaluate HIV/AIDS predetermined health states using TTO and SG relative to an improved health state. Tools were tested for psychometrical properties. RESULTS:Women constituted 64% and 76% of the DART and Entebbe Cohorts. Mean age was 36.5 and 36.7 years, respectively. Participants could discriminate between predetermined HIV/AIDS health states. Deterioration in health status was associated with a reduction in rating scores (VAS), increased willingness to give up time (TTO) and acceptance of increased risk (SG) to achieve a better health state, independent of the participant's actual health state, as measured by CD4 cell counts. CONCLUSION: VAS, TTO and SG have good psychometric properties, making them good candidates for use in resource-constrained settings. Further research in a wider population is necessary to generate an evidence base with which to inform resource allocation decisions.
Authors: Ahmed Ms Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Mark K Markarian; Bernard T Lee; Samuel J Lin Journal: Plast Surg (Oakv) Date: 2015 Impact factor: 0.947
Authors: Karen Y Chung; Gebremedhin B Gebretekle; Andrew Howard; Eleanor Pullenayegum; Mekonen Eshete; Christopher R Forrest; Beate Sander Journal: JAMA Netw Open Date: 2022-07-01
Authors: Ahmed M S Ibrahim; Hani H Sinno; Ali Izadpanah; Joshua Vorstenbosch; Tassos Dionisopoulos; Marc A M Mureau; Adam M Tobias; Bernard T Lee; Samuel J Lin Journal: Plast Reconstr Surg Glob Open Date: 2015-05-07
Authors: Alethea W McCormick; Nadia N Abuelezam; Erin R Rhode; Taige Hou; Rochelle P Walensky; Pamela P Pei; Jessica E Becker; Madeline A DiLorenzo; Elena Losina; Kenneth A Freedberg; Marc Lipsitch; George R Seage Journal: PLoS One Date: 2014-05-27 Impact factor: 3.240
Authors: Bach Xuan Tran; Long Hoang Nguyen; Arto Ohinmaa; Rachel Marie Maher; Vuong Minh Nong; Carl A Latkin Journal: BMC Health Serv Res Date: 2015-01-22 Impact factor: 2.655
Authors: Louis S Matza; Karen C Chung; Katherine J Kim; Trena M Paulus; Evan W Davies; Katie D Stewart; Grace A McComsey; Marshall W Fordyce Journal: Qual Life Res Date: 2017-03-24 Impact factor: 4.147
Authors: Jane Mallewa; Alexander J Szubert; Peter Mugyenyi; Ennie Chidziva; Margaret J Thomason; Priscilla Chepkorir; George Abongomera; Keith Baleeta; Anthony Etyang; Colin Warambwa; Betty Melly; Shepherd Mudzingwa; Christine Kelly; Clara Agutu; Helen Wilkes; Sanele Nkomani; Victor Musiime; Abbas Lugemwa; Sarah L Pett; Mutsa Bwakura-Dangarembizi; Andrew J Prendergast; Diana M Gibb; A Sarah Walker; James A Berkley Journal: Lancet HIV Date: 2018-04-10 Impact factor: 16.070
Authors: S Boyer; M L Nishimwe; L Sagaon-Teyssier; L March; S Koulla-Shiro; M-Q Bousmah; R Toby; M P Mpoudi-Etame; N F Ngom Gueye; A Sawadogo; C Kouanfack; L Ciaffi; B Spire; E Delaporte Journal: Pharmacoecon Open Date: 2020-03